Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Prepaid Assets (2023 - 2025)

Artiva Biotherapeutics (ARTV) has disclosed Prepaid Assets for 3 consecutive years, with $4.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Prepaid Assets rose 50.18% to $4.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.6 million, a 50.18% increase, with the full-year FY2025 number at $4.6 million, up 50.18% from a year prior.
  • Prepaid Assets was $4.6 million for Q4 2025 at Artiva Biotherapeutics, down from $6.5 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $6.7 million in Q2 2025 to a low of $1.1 million in Q4 2023.
  • A 3-year average of $3.8 million and a median of $3.5 million in 2024 define the central range for Prepaid Assets.
  • Biggest YoY gain for Prepaid Assets was 285.16% in 2025; the steepest drop was 50.18% in 2025.
  • Artiva Biotherapeutics' Prepaid Assets stood at $1.1 million in 2023, then soared by 179.95% to $3.1 million in 2024, then skyrocketed by 50.18% to $4.6 million in 2025.
  • Per Business Quant, the three most recent readings for ARTV's Prepaid Assets are $4.6 million (Q4 2025), $6.5 million (Q3 2025), and $6.7 million (Q2 2025).